Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,47 USD | -3,16% | -2,25% | -21,14% |
Vakgebied
Aantal werknemers: 264
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Treatments for B-cell Diseases
100,0
%
| 3 | 100,0 % | 234 | 100,0 % | +8.290,02% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 234 | 100,0 % | +8.290,02% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 58 | 18-05-93 |
Sean Power
DFI | Director of Finance/CFO | 42 | 29-12-11 |
Jenna A. Bosco
IRC | Investor Relations Contact | - | 01-12-11 |
Adam Waldman
PRN | Corporate Officer/Principal | - | 04-06-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 58 | 18-05-93 |
Laurence Charney
BRD | Director/Board Member | 76 | 01-03-12 |
Kenneth Hoberman
BRD | Director/Board Member | 59 | 15-12-14 |
Yann Echelard
BRD | Director/Board Member | 60 | 09-11-12 |
Daniel Hume
BRD | Director/Board Member | 57 | 01-04-15 |
Sagar Lonial
BRD | Director/Board Member | 57 | 29-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 154 462 081 | 140 404 745 ( 90,90 %) | 41 309 ( 0,0267 %) | 90,90 % |
Bedrijfsgegevens
TG Therapeutics, Inc.
3020 Carrington Mill Boulevard Suite 475
27560, Morrisville
+212 554 4484
http://www.tgtherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,14% | 1,95 mld. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers TGTX
- Onderneming TG Therapeutics, Inc.